BackAstria Therapeutics Overview

Astria Therapeutics Inventory

Astria Therapeutics's inventory is $0.

Get informed when a big investor buys or sells

+ Follow
Inventory
$0.00

Peer average

Loading

Astria Therapeutics Inventory History

Loading

Astria Therapeutics vs. peers: Inventory Comparison

Loading

Astria Therapeutics Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Astria Therapeutics (ATXS) FAQ

Astria Therapeutics (ATXS) currently reports a inventory of $0 as of September 2025. In the prior-year period, the figure was $0. Use the charts on this page to explore Astria Therapeutics's inventory history and peer comparisons.

Astria Therapeutics's inventory changed from $0 to $0 (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Astria Therapeutics reported $0 in inventory as of September 2025. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Astria Therapeutics, and consider following ATXS for alerts when major investors trade the stock.

Astria Therapeutics is classified in the Healthcare sector. On inventory, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ATXS with unrelated industries.